These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

351 related articles for article (PubMed ID: 27376863)

  • 1. Integrative concepts of rosacea pathophysiology, clinical presentation and new therapeutics.
    Holmes AD; Steinhoff M
    Exp Dermatol; 2017 Aug; 26(8):659-667. PubMed ID: 27376863
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New insights into rosacea pathophysiology: a review of recent findings.
    Steinhoff M; Schauber J; Leyden JJ
    J Am Acad Dermatol; 2013 Dec; 69(6 Suppl 1):S15-26. PubMed ID: 24229632
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular and Morphological Characterization of Inflammatory Infiltrate in Rosacea Reveals Activation of Th1/Th17 Pathways.
    Buhl T; Sulk M; Nowak P; Buddenkotte J; McDonald I; Aubert J; Carlavan I; Déret S; Reiniche P; Rivier M; Voegel JJ; Steinhoff M
    J Invest Dermatol; 2015 Sep; 135(9):2198-2208. PubMed ID: 25848978
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Signaling pathways and targeted therapy for rosacea.
    Yang F; Wang L; Song D; Zhang L; Wang X; Du D; Jiang X
    Front Immunol; 2024; 15():1367994. PubMed ID: 39351216
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Facial Erythema of Rosacea - Aetiology, Different Pathophysiologies and Treatment Options.
    Steinhoff M; Schmelz M; Schauber J
    Acta Derm Venereol; 2016 Jun; 96(5):579-86. PubMed ID: 26714888
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Current insights into the pathophysiology of rosacea].
    Schauber J; Homey B; Steinhoff M
    Hautarzt; 2013 Jul; 64(7):481-8. PubMed ID: 23760500
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recent advances in understanding and managing rosacea.
    Buddenkotte J; Steinhoff M
    F1000Res; 2018; 7():. PubMed ID: 30631431
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rosacea: part I. Introduction, categorization, histology, pathogenesis, and risk factors.
    Two AM; Wu W; Gallo RL; Hata TR
    J Am Acad Dermatol; 2015 May; 72(5):749-58; quiz 759-60. PubMed ID: 25890455
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rosacea: New Concepts in Classification and Treatment.
    van Zuuren EJ; Arents BWM; van der Linden MMD; Vermeulen S; Fedorowicz Z; Tan J
    Am J Clin Dermatol; 2021 Jul; 22(4):457-465. PubMed ID: 33759078
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inflammation in rosacea and acne: Implications for patient care.
    Fleischer AB
    J Drugs Dermatol; 2011 Jun; 10(6):614-20. PubMed ID: 21961194
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neurovascular and neuroimmune aspects in the pathophysiology of rosacea.
    Schwab VD; Sulk M; Seeliger S; Nowak P; Aubert J; Mess C; Rivier M; Carlavan I; Rossio P; Metze D; Buddenkotte J; Cevikbas F; Voegel JJ; Steinhoff M
    J Investig Dermatol Symp Proc; 2011 Dec; 15(1):53-62. PubMed ID: 22076328
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rosacea as a disease of cathelicidins and skin innate immunity.
    Yamasaki K; Gallo RL
    J Investig Dermatol Symp Proc; 2011 Dec; 15(1):12-5. PubMed ID: 22076322
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rosacea: The cytokine and chemokine network.
    Gerber PA; Buhren BA; Steinhoff M; Homey B
    J Investig Dermatol Symp Proc; 2011 Dec; 15(1):40-7. PubMed ID: 22076326
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical, cellular, and molecular aspects in the pathophysiology of rosacea.
    Steinhoff M; Buddenkotte J; Aubert J; Sulk M; Novak P; Schwab VD; Mess C; Cevikbas F; Rivier M; Carlavan I; Déret S; Rosignoli C; Metze D; Luger TA; Voegel JJ
    J Investig Dermatol Symp Proc; 2011 Dec; 15(1):2-11. PubMed ID: 22076321
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rosacea Pathogenesis.
    Ahn CS; Huang WW
    Dermatol Clin; 2018 Apr; 36(2):81-86. PubMed ID: 29499802
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tranexamic acid ameliorates rosacea symptoms through regulating immune response and angiogenesis.
    Li Y; Xie H; Deng Z; Wang B; Tang Y; Zhao Z; Yuan X; Zuo Z; Xu S; Zhang Y; Li J
    Int Immunopharmacol; 2019 Feb; 67():326-334. PubMed ID: 30578968
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treating Inflammation in Rosacea: Current Options and Unmet Needs.
    Tan J; Jackson JM
    J Drugs Dermatol; 2020 Jun; 19(6):585-591. PubMed ID: 32574018
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Management of facial erythema of rosacea: what is the role of topical α-adrenergic receptor agonist therapy?
    Del Rosso JQ
    J Am Acad Dermatol; 2013 Dec; 69(6 Suppl 1):S44-56. PubMed ID: 24229637
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Papulopustular rosacea, skin immunity and Demodex: pityriasis folliculorum as a missing link.
    Forton FM
    J Eur Acad Dermatol Venereol; 2012 Jan; 26(1):19-28. PubMed ID: 22017468
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mast Cell Stabilizers in the Treatment of Rosacea: A Review of Existing and Emerging Therapies.
    Marchitto MC; Chien AL
    Dermatol Ther (Heidelb); 2021 Oct; 11(5):1541-1549. PubMed ID: 34476755
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.